Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | RPID | Class A Common Stock | Exercise of in-the-money or at-the-money derivative security | $5.39K | +108K | +7.85% | $0.05* | 1.48M | Sep 9, 2021 | Held by Quaker Bioventures II, L.P. | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | RPID | Series A1 Warrant (right to buy) | Exercise of in-the-money or at-the-money derivative security | $0 | -82K | -100% | $0.00* | 0 | Sep 9, 2021 | Class A Common Stock | 82K | $0.05 | Held by Quaker Bioventures II, L.P. | F1, F2 |
transaction | RPID | Series B1 Warrant (right to buy) | Exercise of in-the-money or at-the-money derivative security | $0 | -12.9K | -100% | $0.00* | 0 | Sep 9, 2021 | Class A Common Stock | 12.9K | $0.05 | Held by Quaker Bioventures II, L.P. | F1, F2 |
transaction | RPID | Series B1 Warrant (right to buy) | Exercise of in-the-money or at-the-money derivative security | $0 | -12.9K | -100% | $0.00* | 0 | Sep 9, 2021 | Class A Common Stock | 12.9K | $0.05 | Held by Quaker Bioventures II, L.P. | F1, F2 |
Id | Content |
---|---|
F1 | These shares are held directly by Quaker Bioventures II, L.P. The Reporting Person is an executive manager of Quaker Bioventures Capital II, LLC, the general partner of Quaker Bioventures Capital II, L.P, the general partner of Quaker Bioventures II, LP, and may be deemed to beneficially hold the shares but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein. |
F2 | Immediately exercisable. |